Watch for Aurora shareholder tender response by the December 4 expiry and any regulatory developments from the Alberta Securities Commission hearing on the ATM program. The enhanced offer increases pressure on Aurora's board to engage, but the unsolicited nature and lack of due diligence keep deal completion uncertain.
Price Chart
Executive Summary
Curaleaf filed a Notice of Variation, Change and Extension to its unsolicited offer for Aurora Cannabis, increasing the total implied consideration by 25% to US$5.00 per Aurora share (US$1.00 cash + 0.4013 Curaleaf shares), extending the expiry to December 4, 2026, and providing pro forma financials. The enhanced offer represents an 86% premium to Aurora's unaffected 30-day VWAP, but Aurora's board continues to recommend rejection and has refused due diligence access.
Key Facts
- Total implied consideration increased 25% to US$5.00 per Aurora share (US$1.00 cash + 0.4013 Curaleaf shares), with a Cap Price of US$6.00 per share
- Cash consideration increased 33% from US$0.75 to US$1.00 per share; share consideration increased from 0.3463 to 0.4013 Curaleaf shares per Aurora share
- Offer extended to 11:59 p.m. (Mountain Time) on December 4, 2026
- Offer represents an 86% premium to Aurora's 30-day VWAP of US$2.75 on August 10, 2026 (Unaffected Date), and a 217% premium on an ex-cash basis
- Pro forma combined company would have operations across 17 countries, more than US$1.5 billion LTM revenue, nearly US$350 million LTM Adjusted EBITDA, and at least US$40 million expected annual cost synergies
- Pro forma market capitalization in excess of US$3 billion
- Aurora's board continues to recommend shareholders reject the offer and has not provided Curaleaf with access to non-public information
- Curaleaf filed an application with the Alberta Securities Commission seeking to halt Aurora's ATM program issuances during the offer period
Financial Impact
Total purchase consideration of approximately US$328.7 million (100% scenario) based on Curaleaf's October 5, 2026 closing price of US$9.76; pro forma combined net revenue of US$1.5 billion for the year ended December 31, 2025 and US$775 million for the six months ended June 30, 2026
Risk Factors
- Aurora's board continues to oppose the offer and has refused due diligence, increasing risk of deal failure or further escalation
- The offer is conditional on tender of more than 50% of outstanding shares (statutory minimum) and at least 66 2/3% on a fully diluted basis (waivable)
- Regulatory approvals required and not yet received
- Curaleaf's share price decline could reduce the value of the share consideration component
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-113907 |
| Document: tm2623363d17_8k.htm | 0001104659-26-113907 |
| Document: tm2623363d17_ex99-2.htm | 0001104659-26-113907 |
| Document: 0001104659-26-113907-index-headers.html | 0001104659-26-113907 |
| Document: 0001104659-26-113907-index.html | 0001104659-26-113907 |
| Document: 0001104659-26-113907.txt | 0001104659-26-113907 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 8d ago | 425 / 8-K | $7.86 $8.29 | ▲ +5.47% | ▲ +5.44% | $8.52 (+8.40%) |
Oct 6, 2026 21d ago | 425 | $9.99 $8.82 | ▼ −11.71% | ▼ −11.57% | $8.52 (−14.71%) |
Oct 6, 2026 21d ago | 8-K | $9.99 $8.82 | ▼ −11.71% | ▼ −11.57% | $8.52 (−14.71%) |
Oct 6, 2026 21d ago | 425 | $9.99 $8.82 | ▼ −11.71% | ▼ −11.57% | $8.52 (−14.71%) |
Oct 6, 2026 21d ago | 8-K | $9.99 $8.82 | ▼ −11.71% | ▼ −11.57% | $8.52 (−14.71%) |
Oct 1, 2026 26d ago | 8-K | $9.95 $9.39 | ▼ −5.63% | ▼ −6.79% | $8.52 (−14.37%) |
Oct 1, 2026 26d ago | 8-K | $9.95 $9.39 | ▼ −5.63% | ▼ −6.79% | $8.52 (−14.37%) |
Sep 16, 2026 5w ago | 8-K | $9.98 $11.62 | ▲ +16.43% | ▲ +13.60% | $8.52 (−14.63%) |
Sep 16, 2026 5w ago | 425 | $9.98 $11.90 | ▲ +19.24% | ▲ +17.16% | $8.52 (−14.63%) |
Sep 15, 2026 6w ago | 425 / 8-K | $10.12 $10.45 | ▲ +3.26% | ▲ +2.44% | $8.52 (−15.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers